ATE65997T1 - Isoxazole mit nootropischer wirkung. - Google Patents

Isoxazole mit nootropischer wirkung.

Info

Publication number
ATE65997T1
ATE65997T1 AT88904406T AT88904406T ATE65997T1 AT E65997 T1 ATE65997 T1 AT E65997T1 AT 88904406 T AT88904406 T AT 88904406T AT 88904406 T AT88904406 T AT 88904406T AT E65997 T1 ATE65997 T1 AT E65997T1
Authority
AT
Austria
Prior art keywords
pct
isoxazole
sec
nootropic action
date
Prior art date
Application number
AT88904406T
Other languages
English (en)
Inventor
Angelo Carenzi
Dario Chiarino
Bella Davide Della
Mauro Napoletano
Alberto Sala
Original Assignee
Zambon Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT20589/87A external-priority patent/IT1205014B/it
Priority claimed from IT20590/87A external-priority patent/IT1205015B/it
Application filed by Zambon Spa filed Critical Zambon Spa
Application granted granted Critical
Publication of ATE65997T1 publication Critical patent/ATE65997T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Psychiatry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT88904406T 1987-05-20 1988-05-19 Isoxazole mit nootropischer wirkung. ATE65997T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IT20589/87A IT1205014B (it) 1987-05-20 1987-05-20 Composti ad attivita' nootropa
IT20590/87A IT1205015B (it) 1987-05-20 1987-05-20 Composti ad attivita' nootropa
PCT/EP1988/000445 WO1988009330A1 (en) 1987-05-20 1988-05-19 Isoxazoles with nootropic activity
EP88904406A EP0317588B1 (de) 1987-05-20 1988-05-19 Isoxazole mit nootropischer wirkung

Publications (1)

Publication Number Publication Date
ATE65997T1 true ATE65997T1 (de) 1991-08-15

Family

ID=26327590

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88904406T ATE65997T1 (de) 1987-05-20 1988-05-19 Isoxazole mit nootropischer wirkung.

Country Status (10)

Country Link
US (1) US4985428A (de)
EP (1) EP0317588B1 (de)
JP (1) JPH02500365A (de)
AT (1) ATE65997T1 (de)
AU (1) AU599809B2 (de)
DE (1) DE3864124D1 (de)
DK (1) DK4389A (de)
FI (1) FI89266C (de)
NO (1) NO172120C (de)
WO (1) WO1988009330A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0451790A1 (de) * 1990-04-12 1991-10-16 Hoechst Aktiengesellschaft 3,5-disubstituierte 2-Isoxazoline und Isoxazole, Verfahren zu deren Herstellung, diese enthaltende Mittel und ihre Verwendung
DE10105040A1 (de) * 2001-02-05 2002-08-14 Tell Pharm Ag Hergiswil Tripeptid-Derivate für die Behandlung von postläsionalen Krankheiten des Nervensystems
ITMI20042187A1 (it) 2004-11-16 2005-02-16 Zambon Spa Derivati isossazolici per allievare il dolore neiropatico

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB938420A (en) * 1961-02-01 1963-10-02 Shionogi & Co Isoxazole derivatives and production thereof
GB1039113A (en) * 1964-08-06 1966-08-17 Ucb Sa New n-substituted lactams
DE3336024A1 (de) * 1983-10-04 1985-04-18 Boehringer Ingelheim KG, 6507 Ingelheim 4-amino-l-benzyl-pyrrolidinone und ihre saeureadditionssalze, verfahren zu ihrer herstellung und arzneimittel

Also Published As

Publication number Publication date
FI890173A0 (fi) 1989-01-13
AU599809B2 (en) 1990-07-26
FI89266B (fi) 1993-05-31
NO172120B (no) 1993-03-01
DK4389D0 (da) 1989-01-06
EP0317588A1 (de) 1989-05-31
DE3864124D1 (de) 1991-09-12
FI890173L (fi) 1989-01-13
AU1786988A (en) 1988-12-21
WO1988009330A1 (en) 1988-12-01
FI89266C (fi) 1993-09-10
NO890245D0 (no) 1989-01-19
EP0317588B1 (de) 1991-08-07
NO890245L (no) 1989-01-19
DK4389A (da) 1989-01-06
NO172120C (no) 1993-06-09
US4985428A (en) 1991-01-15
JPH02500365A (ja) 1990-02-08

Similar Documents

Publication Publication Date Title
DK0509019T3 (da) Behandling af humane retrovirale infektioner med 2',3'-dideoxyinosin
FI915282A0 (fi) Mono-n-substituerade 1,4,7,10-tetra -azacyklododekanderivat, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska aemnen.
LV10575A (lv) Izoksazoi-4-karbonskabes amids un hidroksialkiliden-cianetikskabes amids sos savienojumus saturosi astniecibas lidzekli un to pielietojums
ES2053748T3 (es) Oxazoles y tiazoles para el tratamiento de la demencia senil.
JPS53119844A (en) Optically active amino acid-mandelic acid complexes and theire preparation
DK0459256T3 (da) Oxazolidiononer
DK0589995T3 (da) Hidtil ukendte polypeptider og deres anvendelse
ATE113056T1 (de) Künstliche rezeptor-analoge.
BG97123A (bg) Производни на човешка, стимулирана от жлъчните соли, липаза и фармацевтични състави на тяхна основа
ATE65997T1 (de) Isoxazole mit nootropischer wirkung.
DK47688A (da) 5-(3-alkyl-5-tert.butyl-4-hydroxyphenyl)-2-amino-6h-1,3,4-thiadiaziner, deres fremstilling og anvendelse som laegemiddel
DK0607777T3 (da) Anvendelse af leflunomid til inhibering af interleukin 8
DE58903964D1 (de) Fluessige orale formulierung.
TR199801196T2 (xx) Biyolojik aktif benzotiyazolon etanaminler.
ATE135527T1 (de) Bekämpfung von parasitischen nematoden
BG90414A (bg) 2-азабицикло (2,2,1)-хепт-5- ен-2-оцетна киселина и нейни производни, метод за получаване и приложението им
DE3778642D1 (de) Therapeutikum zur behandlung von magengeschwueren.
ES454501A1 (es) Un procedimiento para la preparacion de acidos pirrolidon- carboxilicos sustituidos en n.
DK0589903T3 (da) Aminoalkylsubstituerede 5-mercaptothiazoler, deres fremstilling og anvendelse
DK192890A (da) 24r-scumnol, fremgangsmaade til fremstilling heraf samt anvendelse af samme
DK284588A (da) Beta-lactam-forbindelser, deres fremstilling og anvendelse som laegemidler.
DK0598790T3 (da) Somatropin til forøgelse af kvægs reproduktive ydeevne
SU1586154A1 (ru) 3-(2,4-Дихлорфенил)-4-оксо-3a,4,6,6a-тетрагидрофуро-[3,4-d]изоксазол, проявляющий антигельминтную и анальгетическую активность
NO890287D0 (no) Fremstilling av beta-laktam-antibiotika.
ATE118214T1 (de) Salze von 3-(cis-2,6-dimethylpiperidino)- sydnonimin.